Back to News
Market Impact: 0.2

Context Gains Addition To Russell 2000 And Russell 3000 Indices

Company FundamentalsMarket Technicals & FlowsAnalyst InsightsInvestor Sentiment & Positioning

Context Therapeutics (CNTX) was added to the Russell 2000 and Russell 3000 indices effective June 26, 2026. The change is primarily a technical/flow catalyst that may support modest near-term trading activity, but it doesn’t signal a fundamental earnings or clinical update.

Analysis

Context Therapeutics (CNTX) was added to the Russell 2000 and Russell 3000 indices effective June 26, 2026. The change is primarily a technical/flow catalyst that may support modest near-term trading activity, but it doesn’t signal a fundamental earnings or clinical update.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request Demo

Market Sentiment

Overall Sentiment

mildly positive

Sentiment Score

0.10

Ticker Sentiment

CNTX0.12

More News